Published in Heart Fail Rev on January 14, 2017
Pattern recognition receptors and inflammation. Cell (2010) 21.05
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 8.42
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med (2000) 7.38
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol (2012) 7.32
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity (2012) 6.18
A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88
Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science (2010) 5.84
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 5.47
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet (2001) 5.18
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep (2002) 4.76
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature (2007) 4.21
Tissue-resident macrophages. Nat Immunol (2013) 4.09
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity (2014) 3.54
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation (1992) 3.27
A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A (2009) 3.21
The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat Immunol (2011) 3.19
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 3.15
Comparison of gene expression profiles between human and mouse monocyte subsets. Blood (2009) 3.15
Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol (2008) 3.07
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab (2013) 2.92
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 2.91
The evolution of adaptive immune systems. Cell (2006) 2.77
Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med (2012) 2.69
Origin and functions of tissue macrophages. Immunity (2014) 2.63
Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 2.61
Alterations of skeletal muscle in chronic heart failure. Circulation (1992) 2.58
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell (2013) 2.49
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med (2013) 2.47
Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech (2013) 2.40
C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity (2015) 2.29
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest (2005) 2.24
Beyond stem cells: self-renewal of differentiated macrophages. Science (2013) 2.23
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med (2003) 2.20
Alarmins: awaiting a clinical response. J Clin Invest (2012) 2.19
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res (2005) 2.12
Progressive replacement of embryo-derived cardiac macrophages with age. J Exp Med (2014) 2.10
Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation (1990) 2.06
Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol (2006) 1.94
Origin of monocytes and macrophages in a committed progenitor. Nat Immunol (2013) 1.84
Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation (1989) 1.83
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A (2011) 1.81
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J Leukoc Biol (2006) 1.76
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.75
Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury. Am J Physiol Cell Physiol (2006) 1.74
Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem (2004) 1.69
Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol (1988) 1.66
Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation (1989) 1.64
Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol (1999) 1.61
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J (2007) 1.60
Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet (2010) 1.59
All hematopoietic cells develop from hematopoietic stem cells through Flk2/Flt3-positive progenitor cells. Cell Stem Cell (2011) 1.59
Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol (2003) 1.56
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest (1996) 1.54
Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab (2013) 1.49
Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol (1999) 1.47
Unleashing the therapeutic potential of NOD-like receptors. Nat Rev Drug Discov (2009) 1.39
Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci U S A (2014) 1.38
Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest (1982) 1.31
Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol (1997) 1.31
Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res (1997) 1.27
Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci (Landmark Ed) (2009) 1.25
Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation (1993) 1.22
Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol (1998) 1.19
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Am J Physiol Heart Circ Physiol (2010) 1.17
Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol (2007) 1.14
Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol (2009) 1.13
DAMPs from Cell Death to New Life. Front Immunol (2015) 1.11
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol (2001) 1.09
Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res (2015) 1.05
IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J Immunol (2011) 1.04
Differential effects of chronic monocyte depletion on macrophage populations. Lab Invest (1983) 1.01
Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J Mol Cell Cardiol (2005) 1.00
NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. Endocrinology (2010) 1.00
Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res (2014) 1.00
Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol (2000) 1.00
Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J (1997) 0.94
Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol (2000) 0.93
Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol (1985) (2009) 0.93
Mechanism of induction of muscle protein degradation by angiotensin II. Cell Signal (2005) 0.92
Therapeutic targeting of innate immunity in the failing heart. J Mol Cell Cardiol (2010) 0.89